Edwards Lifesciences Corp’s recent filing unveils that its CVP, EMEACLA Lemercier Jean-Luc M unloaded Company’s shares for reported $1.33 million on Apr 08 ’24. In the deal valued at $92.32 per share,14,400 shares were sold. As a result of this transaction, Lemercier Jean-Luc M now holds 173,849 shares worth roughly $16.05 million.
Then, BOBO DONALD E JR sold 12,500 shares, generating $1,154,142 in total proceeds. Upon selling the shares at $92.33, the CVP,Strategy/Corp Development now owns 39,768 shares.
Before that, MUSSALLEM MICHAEL A sold 29,350 shares. Edwards Lifesciences Corp shares valued at $2,712,418 were divested by the Director at a price of $92.42 per share. As a result of the transaction, MUSSALLEM MICHAEL A now holds 4,486 shares, worth roughly $0.41 million.
BofA Securities upgraded its Edwards Lifesciences Corp [EW] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who increased its forecast for the stock in early February from “an Equal weight” to “an Overweight”. Evercore ISI also remained covering EW and has decreased its forecast on January 04, 2024 with a “an In-line” recommendation from previously “an Outperform” rating. Citigroup revised its rating on December 11, 2023. It rated EW as “a Neutral” which previously was an “a Buy”.
Price Performance Review of EW
On Monday, Edwards Lifesciences Corp [NYSE:EW] saw its stock fall -0.39% to $92.34. Over the last five days, the stock has lost -2.03%. Edwards Lifesciences Corp shares have risen nearly 21.10% since the year began. Nevertheless, the stocks have risen 10.65% over the past one year. While a 52-week high of $96.12 was reached on 03/28/24, a 52-week low of $60.57 was recorded on 01/04/24. SMA at 50 days reached $88.35, while 200 days put it at $78.83. A total of 2.67 million shares were traded, compared to the trading of 3.19 million shares in the previous session.
Levels Of Support And Resistance For EW Stock
The 24-hour chart illustrates a support level at 91.65, which if violated will result in even more drops to 90.97. On the upside, there is a resistance level at 92.94. A further resistance level may holdings at 93.54. The Relative Strength Index (RSI) on the 14-day chart is 52.92, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.56, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.86%. Stochastics %K at 21.64% indicates the stock is a holding.
How much short interest is there in Edwards Lifesciences Corp?
A steep rise in short interest was recorded in Edwards Lifesciences Corp stocks on Mar 15, 2024, growing by 0.36 million shares to a total of 10.45 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 10.09 million shares. There was a rise of 3.44%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 1.75% of the overall stock float, the days-to-cover ratio (short ratio) rose to 2.57.
